Format
Sort by
Items per page

Send to

Choose Destination

SCJFRZ2007B05.b RZ2 Saccharum hybrid cultivar SP80-3280 cDNA clone SCJFRZ2007B05 3', mRNA sequence [Saccharum hybrid cultivar SP80-3280]

Search results

Items: 1 to 20 of 31

1.

An annotated test-retest collection of prostate multiparametric MRI.

Fedorov A, Schwier M, Clunie D, Herz C, Pieper S, Kikinis R, Tempany C, Fennessy F.

Sci Data. 2018 Dec 4;5:180281. doi: 10.1038/sdata.2018.281.

2.

Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.

Peled S, Vangel M, Kikinis R, Tempany CM, Fennessy FM, Fedorov A.

Acad Radiol. 2018 Nov 19. pii: S1076-6332(18)30482-3. doi: 10.1016/j.acra.2018.10.018. [Epub ahead of print]

PMID:
30467073
3.

Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.

Taghipour M, Ziaei A, Alessandrino F, Hassanzadeh E, Harisinghani M, Vangel M, Tempany CM, Fennessy FM.

Abdom Radiol (NY). 2018 Oct 25. doi: 10.1007/s00261-018-1807-6. [Epub ahead of print]

PMID:
30361870
4.

Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 + 4 and 4 + 3 prostate cancer.

Alessandrino F, Taghipour M, Hassanzadeh E, Ziaei A, Vangel M, Fedorov A, Tempany CM, Fennessy FM.

Abdom Radiol (NY). 2018 Jul 31. doi: 10.1007/s00261-018-1718-6. [Epub ahead of print]

PMID:
30066169
5.

Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network.

Newitt DC, Malyarenko D, Chenevert TL, Quarles CC, Bell L, Fedorov A, Fennessy F, Jacobs MA, Solaiyappan M, Hectors S, Taouli B, Muzi M, Kinahan PE, Schmainda KM, Prah MA, Taber EN, Kroenke C, Huang W, Arlinghaus LR, Yankeelov TE, Cao Y, Aryal M, Yen YF, Kalpathy-Cramer J, Shukla-Dave A, Fung M, Liang J, Boss M, Hylton N.

J Med Imaging (Bellingham). 2018 Jan;5(1):011003. doi: 10.1117/1.JMI.5.1.011003. Epub 2017 Oct 10.

6.

Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer.

Hassanzadeh E, Alessandrino F, Olubiyi OI, Glazer DI, Mulkern RV, Fedorov A, Tempany CM, Fennessy FM.

Abdom Radiol (NY). 2018 May;43(5):1237-1244. doi: 10.1007/s00261-017-1297-y.

7.

Evaluation of fitting models for prostate tissue characterization using extended-range b-factor diffusion-weighted imaging.

Langkilde F, Kobus T, Fedorov A, Dunne R, Tempany C, Mulkern RV, Maier SE.

Magn Reson Med. 2018 Apr;79(4):2346-2358. doi: 10.1002/mrm.26831. Epub 2017 Jul 17.

PMID:
28718517
8.

Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.

Fedorov A, Vangel MG, Tempany CM, Fennessy FM.

Invest Radiol. 2017 Sep;52(9):538-546. doi: 10.1097/RLI.0000000000000382.

9.

Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.

Velez E, Fedorov A, Tuncali K, Olubiyi O, Allard CB, Kibel AS, Tempany CM.

Abdom Radiol (NY). 2017 Aug;42(8):2154-2159. doi: 10.1007/s00261-017-1102-y.

10.

Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.

Glazer DI, Hassanzadeh E, Fedorov A, Olubiyi OI, Goldberger SS, Penzkofer T, Flood TA, Masry P, Mulkern RV, Hirsch MS, Tempany CM, Fennessy FM.

Abdom Radiol (NY). 2017 Mar;42(3):918-925. doi: 10.1007/s00261-016-0942-1.

11.

Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.

Hassanzadeh E, Glazer DI, Dunne RM, Fennessy FM, Harisinghani MG, Tempany CM.

Abdom Radiol (NY). 2017 Jan;42(1):278-289. doi: 10.1007/s00261-016-0871-z. Review.

12.

DICOM for quantitative imaging biomarker development: a standards based approach to sharing clinical data and structured PET/CT analysis results in head and neck cancer research.

Fedorov A, Clunie D, Ulrich E, Bauer C, Wahle A, Brown B, Onken M, Riesmeier J, Pieper S, Kikinis R, Buatti J, Beichel RR.

PeerJ. 2016 May 24;4:e2057. doi: 10.7717/peerj.2057. eCollection 2016.

13.

Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) model.

Ciris PA, Balasubramanian M, Seethamraju RT, Tokuda J, Scalera J, Penzkofer T, Fennessy FM, Tempany-Afdhal CM, Tuncali K, Mulkern RV.

NMR Biomed. 2016 Jul;29(7):999-1009. doi: 10.1002/nbm.3556. Epub 2016 May 31.

14.

Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3T MR image-guided targeted biopsy.

Fedorov A, Tuncali K, Panych LP, Fairhurst J, Hassanzadeh E, Seethamraju RT, Tempany CM, Maier SE.

Magn Reson Imaging. 2016 Oct;34(8):1146-54. doi: 10.1016/j.mri.2016.05.012. Epub 2016 May 27.

15.

Bolus arrival time and its effect on tissue characterization with dynamic contrast-enhanced magnetic resonance imaging.

Mehrtash A, Gupta SN, Shanbhag D, Miller JV, Kapur T, Fennessy FM, Kikinis R, Fedorov A.

J Med Imaging (Bellingham). 2016 Jan;3(1):014503. doi: 10.1117/1.JMI.3.1.014503. Epub 2016 Mar 1.

16.

Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence.

Yamauchi FI, Penzkofer T, Fedorov A, Fennessy FM, Chu R, Maier SE, Tempany CM, Mulkern RV, Panych LP.

Magn Reson Imaging. 2015 Jun;33(5):525-30. doi: 10.1016/j.mri.2015.02.006. Epub 2015 Feb 14.

17.

Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.

Fennessy FM, Fedorov A, Penzkofer T, Kim KW, Hirsch MS, Vangel MG, Masry P, Flood TA, Chang MC, Tempany CM, Mulkern RV, Gupta SN.

Magn Reson Imaging. 2015 Sep;33(7):886-94. doi: 10.1016/j.mri.2015.02.008. Epub 2015 Feb 14.

18.

The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.

Fedorov A, Penzkofer T, Hirsch MS, Flood TA, Vangel MG, Masry P, Tempany CM, Mulkern RV, Fennessy FM.

Acad Radiol. 2015 May;22(5):548-55. doi: 10.1016/j.acra.2014.12.022. Epub 2015 Feb 13.

19.

3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates.

Tilak G, Tuncali K, Song SE, Tokuda J, Olubiyi O, Fennessy F, Fedorov A, Penzkofer T, Tempany C, Hata N.

J Magn Reson Imaging. 2015 Jul;42(1):63-71. doi: 10.1002/jmri.24770. Epub 2014 Sep 27.

20.

Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study.

Penzkofer T, Tuncali K, Fedorov A, Song SE, Tokuda J, Fennessy FM, Vangel MG, Kibel AS, Mulkern RV, Wells WM, Hata N, Tempany CM.

Radiology. 2015 Jan;274(1):170-80. doi: 10.1148/radiol.14140221. Epub 2014 Sep 15.

Supplemental Content

Loading ...
Support Center